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 and N. W. Turner*
a 
High affinity and specific binding are cardinal properties of nucleic acids in relation to their biological function and their 
role in biotechnology. To this end, structural preorganization of oligonucleotides can significantly improve their binding 
performance, and numerous examples of this can be found in Nature as well as in artificial systems. Here we describe the 
production and characterization of hybrid DNA-polymer nanoparticles (OligoMIP NPs) as a system in which we have 
preorganized the oligonucleotide binding by molecular imprinting technology. Molecularly imprinted polymers (MIPs) are 
cost-effective "smart” polymeric materials capable of antibody-like detection, but characterized by superior robustness 
and the ability to work in extreme environmental conditions. Especially in the nanoparticle format, MIPs are dubbed as 
one of the most suitable alternatives to biological antibodies due to their selective molecular recognition properties, 
improved binding kinetics as well as size and dispersibility. Nonetheless, there have been very few attempts at DNA 
imprinting in the past due to structural complexity associated with these templates. By introducing modified thymine 
bases into the oligonucleotide sequences, which allow establishing covalent bonds between the DNA and the polymer, we 
demonstrate that such hybrid OligoMIP NPs specifically recognize their target DNA, and that the unique strategy of 
incorporating the complementary DNA strands as "preorganized selective monomers" improves the recognition properties 
without affecting the NPs physical properties such as size, shape or dispersibility.
Introduction 
Nucleic acids must bind their targets with high affinity and 
specificity to play a useful role in biology and biotechnology 
alike. Structural preorganization of oligonucleotides can 
improve binding affinity and specificity, and can be achieved in 
several ways. For example, conformationally locking the sugar 
ring of nucleotides increases oligonucleotide binding affinity 
and specificity to such a degree that it has opened up dozens 
of new opportunities in biotechnology.
1
 
Cellular proteins can achieve this preorganization in other 
ways; e.g., Argonaute proteins prearrange the seed sequence 
of microRNAs into a helical structure which allows this short 
sequence to bind its targets with very high affinity.
2
 
Thus two very different means of preorganization both lead to 
the same biological effect – high binding affinity. 
In this paper, we describe yet another very innovative method 
of conformational preorganization - in this case via the 
artificial molecular recognition method molecular imprinting - 
that leads to an oligonucleotide-polymer hybrid capable of 
binding its targets with high affinity. 
Unlike ordinary polymers, molecularly imprinted polymers 
(MIPs) are tailor-made recognition polymers which can be 











Especially in the nanoparticle format,
7
 MIPs are dubbed as one 
of the most suitable alternatives to biological antibodies due 
to their selective molecular recognition properties, together 
with increased robustness, improved binding kinetics as well 
as size and dispersibility.
8
  
The integration of nucleic acid with molecular imprinting 
technology has already been attempted at the macroscale 
level, with the production of nucleotide imprinted polymeric 
monoliths or films.
9
 The preparation and performance of these 
bulk polymeric materials, despite being historically significant, 
is however very tedious and poorly efficient, resulting in 
polymers which exhibit a distribution of binding sites with non-
homogeneous affinity, as well as possible leakage of unwashed 
template from the material.  
A potential strategy to improve the affinity distribution of the 
binding moieties, as well as to avoid template leakage, is the 
immobilization of the template molecule onto a suitable solid 
support,
10
 which on a nanoscale level has already proven 
advantageous to produce MIP NPs exhibiting nanomolar to 
subnanomolar affinities for specific kinds of targets, also using 
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automatic reactors.11 Nonetheless, even if these imprinted 
nanomaterials are more suitable to mimic the actual antibody 
proteins,
8
 their composition is still based on the same “classic” 
monomers which have been used for the past 30 years to 
produce bulk MIPs, definitely not tailored for the specific 
target molecule. As a result, when considered against the 
breadth of molecular imprinting research, materials that target 
DNA as a template are in a significant minority. 
To try addressing this issue, in our previous work we have 
introduced chemically modified nucleobases (complementary 
to the template) into the polymer composition used during the 
solid-phase synthesis of the MIP NPs. We found that the 
incorporation of such “polymerizable nucleosides” results in an 
overall improved recognition performance in comparison to 
the MIP NPs lacking this modification.
12
 We have also 
demonstrated that an aptamer sequence can be incorporated 
into a MIP NP to yield a nanoparticle with specific, high-affinity 
binding of a small molecule target.
13
 Given that these “hybrid” 
materials utilize a ssDNA sequence as the recognition element, 
the use of them to bind specific sequences of ssDNA was an 
obvious area to investigate.  
As a consequence, here we present the first hybrid 
oligonucleotide-polymer system (OligoMIP NPs) designed to 
recognize a complementary strand, wherein polymeric NPs 
have been imprinted for the recognition of the 12mer 
sequence 5’-AGC TAG CTA GCT-3’ as a model oligonucleotide 
template. The opportunities that could be afforded by such 
nanoparticulate recognition elements capable of selective 
binding to a known sequence are very interesting in the fields 
of bioanalytical chemistry. In addition, the methodology 
described here has the potential to overcome the 
heterogeneity problems observed in prior attempts at 
m o l e c u l a r  i m p r i n t i n g  
 
Fig. 1 Schematic of the template DNA sequence (5’-AGC TAG CTA GCT-3’) immobilized 
through the 5’-phosphate group. 
using DNA as a target, and which have hindered the broad 
applications of MIPs as DNA recognition systems. 
Results and discussion 
The template DNA sequences have been immobilized on 75 
µm glass beads as solid support by 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC)-mediated amine 




Then, the complementary oligonucleotide sequences (i.e. 5’-
AGC TAG CTA GCT-3’) or control sequences have been allowed 
to attain thermodynamic equilibrium with the immobilized 
template strand through non-covalent interactions. These 
“monomer” sequences have been chemically synthesized 
either by using 5’-phosphate-linked Acrydite™ modifications,
15
 
or by introducing C-5 alkene-modified 2’-deoxyuridine residues 
into the DNA strand,
12
 thus resulting in single or multiple 
covalent anchoring points between the oligonucleotide and 
the polymer matrix (Fig. 2a).
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Fig. 2 a) Schematics for the preparation of polymerizable oligonucleotide sequences used as recognition elements in the MIP NPs composition. Polymerizable sequences bear 
either a single polymerizable moiety through Acrydite™ 5’-modifier (marked as “ACRYD”) or several polymerizable moieties through C-5 alkene 2’-deoxyuridine modifications 
(indicated as “T*”). b) Schematic representation of the solid-phase synthesis and selection of OligoMIP NPs. The polymerizable sequence is incubated first with the solid phase 
bearing the oligonucleotide template. After this step the remaining classical monomers are added to the solid phase bearing at this point the complex between the 
complementary DNA strands, and the polymerization is initiated. Low-affinity NPs and unreacted monomers are washed at relatively low temperature (20 °C) using PBS (0.005 M, 
pH 7.4). The temperature is then increased (60 °C) and high-affinity MIP NPs are eluted from the solid phase using water. 
These anchoring points allow the oligonucleotides to 
participate in the subsequent radical polymerization process: 
indeed, once both the template and the recognition 
oligonucleotide are in equilibrium, additional monomers and 
cross-linkers are added and the polymerization is initiated. 
After polymerization, unreacted monomers and any low-
affinity nanoparticles are washed away, then the high-affinity 
nanoparticles are eluted at higher temperature and reduced 
ionic strength (Fig. 2b).
11, 12, 13, 16
 
We tested several modified oligonucleotide and control 
sequences (Fig. 2a), achieving in all cases an incorporation 
level achieved for the oligonucleotide sequences into the MIP 
NPs of ~70% (w/w) of the initial feed ratio. Plain MIP NPs have 
also been prepared for comparison purposes by imprinting the 
immobilized oligonucleotide template without introducing any 
DNA monomer in the preparation. In all cases the immobilized 
oligonucleotide was 5’-AGC TAG CTA GCT-3’. 
The Acrydite™ modification can only be incorporated at the 5’-
terminal end of the oligonucleotide sequence, whilst the C-5 
alkene-modified 2’-deoxyuridine residues can provide multiple 
anchoring points between the DNA strand and the MIP matrix 
(Fig. 2). This should allow the oligonucleotide to be held firmly 
into the cross-linked polymer matrix, thus favoring the best 
possible recognition performance. Moreover, another 
advantage of this “nucleotide” modification strategy in 
comparison to the Acrydite™ method is that the frequency and 
the location of base modifications could be entirely tailor-
made as needed. In this work we only modified dU residues, 
but there are other examples in the literature in which 




Dynamic light scattering (DLS) analysis reported hydrodynamic 
diameter values ranging from 10 nm to 33 nm (Table 1). 
Table 1. Particle size distribution and Zeta potential analyses of Plain and OligoMIP NPs 
in PBS 0.1 M at pH 7.4. Error bars represent ±1 SD (n = 3). 





Plain 11.6 ± 0.5 -10.5 ± 0.3 
T12 ACRYD 5.1 ± 0.3 -5.8 ± 0.3 
T*12 16.6 ± 0.6 -24.5 ± 0.7 
(AGCT)3 ACRYD 9.6 ± 3.4 -9.0 ± 0.3 
(AGCT*)3 16.2 ± 2.5 -13.4 ± 1.0 
 
These data are consistent with the transmission electron 
microscopy (TEM) analysis (taking into account the swelling in 
aqueous medium), which showed that OligoMIP NPs appeared 
spheroidal in shape with their size ranging between 5-15 nm 
(Fig. 3). Looking at the DLS data more in detail, in relation to 
the Plain MIP NPs, we can observe that the incorporation of 
ACRYD modified oligonucleotides [T12 ACRYD and (AGCT)3 
A C R Y D ]  
 
Fig. 3 Transmission Electron Microscopy (TEM) image of (AGCT*)3 MIP NPs at 30000× 
magnification. Inset details the spheroidal shape and regular size distribution of the 
OligoMIP NPs (80000× magnification). 
resulted in slightly smaller NPs sizes, whereas incorporation of 
the modified deoxyuridine-containing oligonucleotides [T*12 
and (AGCT*)3] led to slightly larger OligoMIP NPs (Table 1). 
We hypothesize that the changes observed in the particle 
diameter might depend on the different modification of the 
oligonucleotide sequences. Specifically, since the Acrydite™ 
modification possesses more of a hydrophobic character due 
to the introduction of a C6 carbon chain at the end of the DNA 
sequence in comparison to the C-5 alkene deoxyuridine 
modification, this could result in a more “compact” 
conformation and smaller size in buffer solution. 
This hypothesis seems to be supported by the Zeta potential 
data (Table 1), according to which the T*12 and (AGCT*)3 
OligoMIP NPs exhibited a more negative Zeta potential value 
than Plain MIP NPs, which appears to indicate that these 
oligonucleotide monomers may contribute to the stabilization 
of the MIP NPs dispersions. On the other hand, T12 ACRYD and 
(AGCT)3 ACRYD OligoMIP NPs exhibited a less negative or more 
similar Zeta potential value in comparison to Plain MIP NPs, 
which might indicate that these oligonucleotide monomers 
could either destabilize or not exhibit an effect on the MIP NPs 
dispersions. 
The MIP NPs produced were then analyzed for their template 
recognition performance by quartz crystal microbalance (QCM) 
microgravimetric analysis.
12, 13, 18
 The (AGCT)3 oligonucleotide 
template [or a polyA 12mer (A12) control sequence] was 
immobilized onto the gold crystal surface using comparable 
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immobilization conditions as the ones exploited on the solid 
phase used during imprinting. This is to ensure that the DNA 
template orientation during rebinding is the same as during 
the production process of the MIP NPs. 
 
Fig. 4 Rebinding analysis by QCM to template (AGCT)3 and control (A12) derivatized gold surfaces: (a) a typical QCM sensorgram obtained by rebinding different control MIP NPs 
(Plain, T12 ACRYD, and T*12 MIP NPs) to (AGCT)3 oligonucleotide; (b) rebinding performance of control NPs (Plain, T12 ACRYD, and T*12 MIP NPs) to (AGCT)3; (c) a typical QCM 
response obtained by rebinding (AGCT)3 ACRYD MIP NPs and (AGCT*)3 MIP NPs to the complementary (AGCT)3 oligonucleotide; (d) rebinding performance of (AGCT)3 ACRYD and 
(AGCT*)3 MIP NPs to the complementary (AGCT)3 oligonucleotide; (e) a typical QCM sensorgram obtained by injecting (AGCT)3 ACRYD and (AGCT*)3 MIP NPs onto a A12 
functionalized gold surface; (f) rebinding performance of (AGCT)3 ACRYD and (AGCT*)3 MIP NPs to A12 oligonucleotide. Drop in frequency (on the Y-axis) indicates the binding event 
of the MIP NPs to the surface-immobilized oligonucleotide sequence. Arrows indicates the point of injection. A baseline stability value of ±0.2 Hz has been reached between 
injections. The temporary increase in frequency immediately after the injection point is an artifact due to the pressure variation caused by the injection itself. QCM measurements 
were performed in PBS (0.03 M, pH 7.4) at 20 °C for the NPs concentrations from 0.125 to 2 µg mL⁻¹. Error bars represent ±1 SD (n = 3). 
Several concentrations (from 0.125 to 2 µg mL
−1
) of the high-
affinity fraction of OligoMIP NPs [(AGCT*)3, (AGCT)3 ACRYD, 
T*12, T12 ACRYD], or Plain MIP NPs were sequentially flowed 
(from the lowest to the highest concentration) on the gold 
crystal bearing the template or the control sequence, and their 
binding behaviour was recorded. The results of these analyses 
are detailed in Fig. 4. The QCM sensorgrams indicated that the 
Plain, T12 ACRYD and T*12 MIP NPs (Fig. 4a and 4b) did not 
exhibit significant binding when tested against QCM crystals 
bearing the (AGCT)3 template. None of these nanoparticles 
contained the complementary polymerizable oligomer. 
We have previously observed in other contexts that Plain MIP 
NPs could show an imprinting effect thanks solely to the 
“classical” monomers, though the addition of a specific 
monomer (T*) resulting in an improved rebinding performance 
towards the nucleoside dA template.
12
 However, in the case of 
the oligonucleotide recognition in this study, the Plain MIP NPs 
exhibited no measurable imprinting effect, showing that 
classical monomers may lack sufficiently complex moieties to 
imprint an oligonucleotide sequence. 
Moreover, inclusion of a non-complementary oligonucleotide 
(T12 ACRYD and T*12 MIP NPs, Fig. 4a and 4b) did not help with 
the imprinting. Thus the binding observed for complementary 
sequences is not simply related to the presence of a 
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Interestingly, even when the complementary (AGCT)3 was 
incorporated through a 5’-Acrydite™ modification [(AGCT)3 
ACRYD MIP NPs], it exhibited very poor recognition 
performance (Fig. 4c and 4d). In contrast, the MIP NPs in which 
the DNA modification strategy involved multiple anchoring 
points [(AGCT*)3 MIP NPs] showed excellent binding behaviour 
(Fig. 4c and 4d). This suggests that multi-point incorporation, 
which may preorganize the oligonucleotide conformation into 
an appropriate helical structure, is significantly more effective 
at developing nanoparticles with appropriate binding cavities 
for their targets. 
To further explore these results, we took the “active” 
nanoparticles which showed strong binding to (AGCT)3, 
[(AGCT)3 ACRYD and (AGCT*)3 MIP NPs] and tested them for 
binding to another immobilized strand, A12 (Fig. 4e and 4f). 
The sensorgrams are comparable to the binding levels 
observed by the non-specific NPs shown in Fig. 4b. This 
suggests that none of the (AGCT)3 OligoMIP NPs bound to the 
non-complementary A12 sequence, thus confirming that the 
specific binding event observed in the case of (AGCT*)3 MIP 
NPs requires the presence of the correct complementary DNA 





methylethylenediamine (TEMED), ammonium persulphate 
(APS), acrylic acid (AAc), N,N'-methylenebisacrylamide (BIS), N-
tert-butylacrylamide (TBAm), 3-aminopropyltriethyloxy-silane 
(APTES), cysteamine, glass beads, SPE cartridges and frits, 
toluene, methanol and acetone were purchased from Sigma-
Aldrich (UK). Sodium hydroxide, sulfuric acid, 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC), imidazole, 
ethylenediaminetetraacetic acid (EDTA) and phosphate 
buffered saline (PBS) were purchased from Fisher Scientific 
(UK). Ethanol and hydrogen peroxide were purchased from 
VWR (UK). DNA sequences bearing the Acrydite™ and 
Phosphate (Phos) modification were purchased from 
Integrated DNA Technologies, Inc (USA). Carboxy-dT-CE 
Phosphoramidite was purchased from Link (UK). Double-
distilled water (Millipore) was used for analysis. All chemicals 
and solvents were analytical or HPLC grade and were used 
without further purification. 
 
Synthesis of polymerizable oligomer sequences [T*12, (AGCT*)3] 
Oligonucleotides were synthesized under standard conditions 
at 1 µmol scale on an Applied Biosystems 394 oligonucleotide 
synthesizer. The oligomers were deprotected and released 
from the support by treatment with concentrated aqueous 
NH3 at 55 °C for 16 h. The solutions were concentrated to 
dryness, resuspended in water and desalted using NAP-10 
columns (GE Healthcare). Oligonucleotide masses were 
verified using a Bruker micrOTOF LCMS system. 
 
Preparation of (AGCT)3-derivatized glass beads as affinity media 
Glass beads (125 g, 75 µm diameter, Supelco) were activated 
by boiling in NaOH (1 M) for 10 min, then washed thoroughly 
with double-distilled water at 60 °C, acetone and finally dried 
at 80 °C. They were then incubated in a solution of APTES (2 %, 
v/v) in anhydrous toluene overnight at room temperature, 
then washed with acetone and dried under vacuum. The 5’-
Phos-AGC TAG CTA GCT-3’ template sequence (425 nmol) was 
activated in 283 µL PBS (0.01 M, EDTA 0.01 M, pH 7.2) by 
adding 40 µL EDC and immediately transferring this solution 
into 22.5 g of APTES-derivatized glass beads suspended in 10 
mL of imidazole buffer (0.1 M, pH 6.0). The glass beads were 
incubated with the DNA template for 2 h at 50 °C and then 
overnight at room temperature (0.67 mL solution/g glass 
beads). The derivatized beads were washed thoroughly with 
double-distilled water and dried under vacuum. After this step 
the glass beads were used straight away for the synthesis of 
the MIP NPs without further storage. The immobilization of 
the template was confirmed spectrophotometrically (at λ = 
260 nm) by analyzing the amount of DNA unbound to the glass 
beads and found in the washings collected from the 
immobilization step. 
 
Solid-phase synthesis of Plain and OligoMIP NPs 
A solution (2.5 mL) of each polymerizable DNA oligomer 
sequence in PBS (0.005 M, pH 7.4) was degassed by purging 
with Ar for 10 min and then incubated for 1 h at room 
temperature in a 14 mL glass vial closed using a Teflon screw-
cap and containing 5 g of (AGCT)3-derivatized glass beads (0.67 
mL solution/g glass beads), for a total of five polymerization 
vials [Plain MIP NPs, T12 ACRYD MIP NPs, (AGCT)3 ACRYD MIP 
NPs, T*12 MIP NPs, (AGCT*)3 MIP NPs]. In the case of Plain MIP 
NPs, 2.5 mL of PBS were added to maintain the incubation 
conditions similar to the other samples. Prior to the addition of 
the oligomer solutions, the vials containing the solid phase 
were degassed under vacuum and the air inside the vials then 
replaced with Ar (3 times). In the meantime the following 
monomers were dissolved in PBS (0.005 M, pH 7.4, 50 mL): 
NIPAm (39 mg, 0.35 mmol, 53%), BIS (2 mg, 0.01 mmol, 2%), 
TBAm (33 mg, 0.26 mmol, 40%) and AAc (2.2 µL, 0.03 mmol, 
5%). TBAm was previously dissolved in EtOH (1 mL) and then 
added to the aqueous solution. The total monomer 
concentration was 13 mM at this stage. The solution was 
degassed under vacuum and sonication for 10 min, and then 
purged with Ar for 30 min. After this time, aliquots of 2.5 mL of 
solution were transferred in the vials previously incubated 
with the polymerizable DNA, thus reaching a total volume of 5 
mL and a final monomer concentration of 6.5 mM. The 
polymerization was started by adding an APS aqueous solution 
(50 µL, 60 mg mL
-1
) and TEMED (1.5 µL). The polymerization 
was then carried out at 20 °C for 20 h. After the 
polymerization, the contents of the vials were transferred into 
SPE cartridges fitted with a polyethylene frit (20 μm porosity) 
in order to perform the temperature-based affinity separation 
of MIP NPs. The temperature of PBS and the SPE cartridges 
was kept at 20 °C (same as the polymerization step). Washing 
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was performed with 3 × 5 mL of PBS (0.005 M, pH 7.4), 
applying manual pressure with a syringe if needed. This was 
done in order to remove non-polymerized monomers and low-
affinity MIP NPs. The effectiveness of the washing was verified 
by measuring the UV absorbance of washing aliquots, in order 
to ensure complete monomer removal as well as to quantify 
the incorporation of polymerizable DNA into the polymer 
matrix (by difference of the absorbance measured at λ = 260 
nm). Afterwards the SPE cartridges containing the solid phase 
with high-affinity MIP NPs attached were heated up to 60 °C 
and eluted with 5 × 5 mL H2O at 60 °C. The concentration of 
the nanoparticles fractions has been evaluated by evaporation. 
 
Transmission Electron Microscopy (TEM) analysis 
TEM images of MIP NPs were taken using a JEOL JEM 1400, 
120kV high contrast TEM equipped with an AMT XR60 mid-
mount digital camera (11 megapixels). Samples for the analysis 
were prepared by depositing a drop of the MIP NPs solution, 
previously filtered through a 0.45 μm PTFE syringe filter, on a 
carbon-coated TEM copper grid (300 mesh, from Agar 
Scientific, UK), blotting away the excess and leaving them to 
dry overnight at room temperature. 
 
Dynamic Light Scattering (DLS) analysis 
The MIP NPs samples for DLS were prepared in deionized H2O, 
sonicated for 5 minutes, then filtered through 0.45 µm PTFE 
syringe filters and analyzed in Quartz SUPRASIL (1.5 × 1.5 mm) 
cuvette at 25 °C by using Malvern Viscotek DLS (Malvern 
Instruments Ltd.) equipped with OMNISIZE 3.0 software. 
 
Zeta Potential analysis 
The MIP NPs were dispersed in PBS (10 mM, pH 7.4) and 
transferred to DTS1060C clear disposable 1 mL zeta flow-cells. 
The analysis was done on Malvern Zetasizer Nano Z (Malvern 
Instruments Ltd.) using the Smoluchowski model. 
 
Treatment of Quartz Crystal Microbalance (QCM) crystals and 
surface immobilization of templates 
QCM crystals (5 MHz Cr/Au, polished, Testbourne Ltd., UK) 
were cleaned by immersion in Piranha solution (H2SO4/H2O2, 
3/1, v/v) for 5 min. Caution! This mixture is highly corrosive; 
hence extreme care is required during this process. Then they 
were thoroughly rinsed with double-distilled water and left in 
MeOH overnight. The immobilization of the templates has 
been performed by incubating the crystals in a solution of 
cysteamine (0.2 mg mL
-1
) in EtOH at 4 °C for 24 h, after which 
they have been washed with EtOH and incubated for at least 
48 h at room temperature in a 10 mL solution of 5’-Phos-AGC 
TAG CTA GCT-3’ template sequence (425 nmol) in imidazole 
buffer (0.1 M, pH 6.0). The template was previously activated 
in 283 µL PBS (0.01 M, EDTA 0.01 M, pH 7.2) by adding 40 µL 
EDC (same activation as for the immobilization onto the glass 
beads). Once the immobilization was completed, the crystals 
were washed thoroughly with double-distilled water before 
being mounted in the QCM flowcell. 
 
QCM microgravimetric analysis of Plain and OligoMIP NPs 
Plain and OligoMIP NPs adsorption to the (AGCT)3 template 
was monitored using a QCM200 5 MHz quartz crystal 
microbalance (Stanford Research Systems, UK). The modified 
QCM chips were maintained hydrated during mounting in the 
QCM flowcell. MIP NPs solutions and running buffer were 
introduced using an Instech P720 peristaltic pump equipped 
with 0.020” ID tubing (Linton Instrumentation, UK) and flowing 
at 0.1 μL min
-1
. The QCM chip bearing the template was first 
stabilized in running buffer (PBS 0.003 M, pH 7.4) at 20 °C until 
the system reached a stable baseline. Affinity analysis was 
carried out by sequentially by flowing each MIP NPs solution 
for 5 min (500 µL) and analyzing the sensor response for 15 
min. This process was repeated over the concentration range 




In conclusion, hybrid OligoMIP NPs were successfully produced 
for a model oligomer DNA sequence (5’-AGC TAG CTA GCT-3’) 
by exploiting a modified oligonucleotide bearing multiple 
polymerizable moieties as a tailored functional monomer. 
Nanoparticles were obtained using a solid-phase imprinting 
polymerization strategy in which template-derivatized glass 
beads double as an affinity matrix for production as well as 
selection and purification of synthesized MIP NPs.  
The physical analysis of OligoMIP NPs showed narrow particle 
size distributions and spheroidal shapes, with a size 
comparable to natural antibodies.
19
 
QCM microgravimetric analysis of the synthesized OligoMIP 
NPs confirmed that maximum specificity and selectivity are 
achieved only when the correct complementary DNA sequence 
is structurally supported and locked in position into the MIP 
matrix by multiple anchoring points provided by the 
polymerizable nucleotides. It is hypothesized that the use of a 
single anchor point allowed the DNA structure entrapped 
within the polymer to alter shape and hence be unviable as a 
target site, whereas the multiple point binding fixed the 




Such OligoMIP nanosystems could potentially be applied for 
the development of biosensors or even in vivo therapeutics 
and diagnostics. 
4, 20
 Our previous work on aptamer-
functionalized MIPs showed that imprinting conferred a very 
high level of nuclease stability on the oligonucleotide, giving 
significant advantages when working in biological contexts.
13
 
We are currently investigating the possibility of using these 
materials for these and other applications. 
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